Connecting Science and Society

Latest Articles

Dr Yan M Yufik – From Machine Learning to Machine Understanding

Dr Yan M Yufik – From Machine Learning to Machine Understanding

Despite dramatic advances in neuroscience and biology in the 20th and 21st centuries, our understanding of the brain remains very limited. Dr Yan M Yufik, Head at Virtual Structures Research Inc, USA, is a physicist and cognitive scientist who has spent over 20 years combining experimental findings and theoretical concepts in domains as diverse as neuroscience and thermodynamics to form a theory of the brain. His focus has been on elucidating the mechanisms underlying human understanding and applying the results to the design of machines that can not only learn but understand what they are learning.

Dr Susanne Zeilinger – Fighting Fungi with Fungi: Utilising Chemical Warfare for Human Benefit

Dr Susanne Zeilinger – Fighting Fungi with Fungi: Utilising Chemical Warfare for Human Benefit

Fungi feeding on other fungi (mycoparasites) represent a promising alternative to chemical fungicides for plant disease control. They also have potential applications in medicine and across industry. Dr Susanne Zeilinger and her team from the University of Innsbruck in Austria are working to identify and characterise the genes and gene products that are active during the interactions of antagonistic fungi. This critical work is paving the way for improvement of fungal strains as biotechnological workhorses in plant protection and beyond.

Dr Akihiro Ito – Improving the Diagnosis of Legionnaires’ Disease

Dr Akihiro Ito – Improving the Diagnosis of Legionnaires’ Disease

Legionella bacteria are known to cause Legionnaire’s disease, a potentially severe and lethal form of pneumonia. The bacteria can be classified into different serogroups forming specific sub-types of L. pneumophila. In humans, serogroup 1 is the most common cause of pneumonia, being responsible for approximately 80% of all cases. However, the other subgroups can also cause pneumonia, resulting in a range of outcomes from mild to severe, and these are more difficult to accurately detect. Dr Akihiro Ito at Kurashiki Central Hospital, Japan, is advancing the detection of all forms of L. pneumophila to facilitate more timely healthcare interventions for Legionnaires’ disease.

The American Society of Agricultural and Biological Engineers

The American Society of Agricultural and Biological Engineers

Representing approximately 7,000 members in over 100 countries, the American Society of Agricultural and Biological Engineers (ASABE) is devoted to advancing engineering research applicable to agriculture, food and biological systems. In this exclusive interview, we have had the pleasure of speaking with Dr Sue Nokes, President of ASABE, who discusses the myriad of ways that the Society accelerates this diverse research field, towards ensuring global food, energy and water security, in the face of our changing climate and growing human population.

Dr Jarrad Scarlett – Targeting the Brain in Type 2 Diabetes: Therapeutics to Induce Remission

Dr Jarrad Scarlett – Targeting the Brain in Type 2 Diabetes: Therapeutics to Induce Remission

Type 2 diabetes (T2D) is among the most impactful and costly biomedical challenges confronting society. Current treatment regimens for T2D rely upon daily drug dosing and frequent glucose monitoring to normalise blood glucose levels. However, these medications can only delay disease progression and frequently have undesired side effects including hypoglycaemia and weight gain. Growing evidence supports a key role for the brain in glucose homeostasis and diabetes pathogenesis. Dr Jarrad Scarlett and his research team at the University of Washington and Seattle Children’s Hospital are working on the development of novel pharmaceuticals to target the brain to induce sustained remission of T2D.

Dr Amy Schmidt – iAMResponsibleTM: Educating Food Producers & Consumers About Antimicrobial Resistance

Dr Amy Schmidt – iAMResponsibleTM: Educating Food Producers & Consumers About Antimicrobial Resistance

Antimicrobial resistance (AMR), the acquired ability of microorganisms to withstand the effects of medications used to treat them, is a serious and growing threat to public health. In collaboration with experts from various US institutions, Dr Amy Schmidt at the University of Nebraska-Lincoln has developed a program called the iAMResponsibleTM Project, aimed at educating consumers, agricultural producers and others on the risks associated with AMR, as well as strategies to mitigate these risks.

Latest Publications

Scientia Issue #127

Scientia Issue #127

  STRENGTHENING THE STEM COMMUNITY THROUGH INCLUSIVE EDUCATION   In this critical issue of Scientia, we showcase an inspiring array of projects, each seeking to enhance science, technology, engineering and mathematics (STEM) education worldwide....

Scientia Issue #126

Scientia Issue #126

  SHAPING A BETTER WORLD THROUGH SOCIAL SCIENCE AND HUMANITIES RESEARCH   In this captivating edition of Scientia, we showcase a diverse selection of research achievements across the humanities and social sciences, from history to linguistics, and...

Scientia Issue #125

Scientia Issue #125

  CELEBRATING DISCOVERY AND INNOVATION IN GENETIC SCIENCE   This important issue of Scientia showcases the vital work of scientists in the field of genetics, the branch of biology concerned with the study of genes, genetic variation, and heredity....

Editor’s Pick

Dr Jarrad Scarlett – Targeting the Brain in Type 2 Diabetes: Therapeutics to Induce Remission

Dr Jarrad Scarlett – Targeting the Brain in Type 2 Diabetes: Therapeutics to Induce Remission

Type 2 diabetes (T2D) is among the most impactful and costly biomedical challenges confronting society. Current treatment regimens for T2D rely upon daily drug dosing and frequent glucose monitoring to normalise blood glucose levels. However, these medications can only delay disease progression and frequently have undesired side effects including hypoglycaemia and weight gain. Growing evidence supports a key role for the brain in glucose homeostasis and diabetes pathogenesis. Dr Jarrad Scarlett and his research team at the University of Washington and Seattle Children’s Hospital are working on the development of novel pharmaceuticals to target the brain to induce sustained remission of T2D.

Dr Sigrid Netherer – A Robust New Framework for Bark Beetle Management

Dr Sigrid Netherer – A Robust New Framework for Bark Beetle Management

The economically important Norway spruce tree naturally grows in mountain forest ecosystems, and is the main tree species in vast plantations across Europe. However, in the recent decades, its risk of attack by the destructive Eurasian spruce bark beetle has considerably increased. Although the complex interactions of host, pest and environmental conditions that allow attacks to occur have been extensively studied for more than 100 years, predictive tools for pest management still suffer from knowledge gaps. Dr Sigrid Netherer and her team at the University of Natural Resources and Life Sciences (BOKU), Austria, have been investigating the role of drought stress and other environmental and biotic factors on infestations, to produce a novel universal framework for monitoring and predicting bark beetle outbreaks.

Subscribe

Subscribe now!


Blog

Merits of getting help with your public sci-comm

Merits of getting help with your public sci-comm

Most universities and companies have a media department to take care of related matters, and they can do a good job. The problem with the latter is, the skill set required for public sci-comm is a little different and it is often better carried out by someone with experience in the area. Furthermore, if a representative does all of your public sci-comm, no one will get to know you, or your science, on an intimate level.

Twitter

#AntibioticResistance is a growing threat to #publichealth. Experts from @UNLincoln & other institutes developed the iAMResponsible program, which educates consumers & #agricultural producers on the risks of resistance & how to reduce risk. Read more: https://t.co/14UoRdLmot #AMR

2

Read our interview with the President of the American Society of #Agricultural & #Biological #Engineers, who discusses how @ASABEorg accelerates #research towards ensuring global #food, #energy & #water security, particularly in the face of #climatechange: https://t.co/lKE1eJMNva

2
Load More...

BARRIER FREE POLICY

No pay walls. No subscription walls. No language barrier. Simple instant public access to science – opening a dialogue between science and society.

CREATIVE COMMONS

We publish under the Creative Commons Attribution-NonCommercial 4.0 (CC BY-NC 4.0)

DECLARATION ON RESEARCH ASSESSMENT (DORA)

We support and encourage the DORA initiative

OPEN ACCESS POLICY

Scientia adheres to the open access policy. Open Access (OA) stands for unrestricted access and unrestricted reuse.

DOI

Scientia is officially registered with CrossRef making our research content easy to find, cite, link, and assess.